Showing results (71-80 of 286) with videos related to
Sort By:
Pageof 29
Clinical Research and Regulatory Affairs|September 25, 2015
Special population considerations and regulatory affairs for clinical researchKristin N Grimsrud, Catherine M T Sherwin, Jonathan E Constance, et al.Expert Opinion on Drug Safety|August 20, 2010
Dexmedetomidine: pediatric pharmacology, clinical uses and safetyFelice Su, Gregory B HammerThe Journal of Thoracic and Cardiovascular Surgery|August 19, 2014
Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infantsAdam S Himebauch, Susan C Nicolson, Martha Sisko, et al.Journal of Pediatric Hematology/Oncology|May 15, 2013
Evaluation of the retinoids with cisplatin and vincristine in xenograft models of neuroblastomaRobin E Norris, Vu T Nguyen, Peter C AdamsonPediatric Blood & Cancer|August 19, 2011
Preclinical evaluation of pemetrexed in pediatric solid tumorsRobin E Norris, Eric F Rappaport, Peter C AdamsonJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Pediatric phase I trials in oncology: an analysis of study conduct efficiencyDebra P Lee, Jeffrey M Skolnik, Peter C AdamsonEuropean Journal of Drug Metabolism and Pharmacokinetics|September 1, 2018
Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ AfricansJessie Torgersen, Scarlett L Bellamy, Bakgaki Ratshaa, et al.Contemporary Clinical Trials|March 16, 2026
A study within a trial evaluating supplemental, reinforced risk-based training to reduce implementation barriers in a pediatric multicenter randomized control trialDanielle J Green, Valeriya Vasenina, Kelsee Meyerhoffer, et al.The Journal of Antimicrobial Chemotherapy|August 2, 2019
Mechanisms of antimicrobial-induced nephrotoxicity in childrenKevin J Downes, Molly Hayes, Julie C Fitzgerald, et al.JAMA Oncology|June 4, 2018
New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics: A ReviewSonya Das, Raphaël Rousseau, Peter C Adamson, et al.Pageof 29